5 Best Biotech Stocks To Buy For 2021

4. GlaxoSmithKline plc (NYSE: GSK)

GlaxoSmithKline (NYSE: GSK) is a United Kingdom-based drug manufacturer that has a market cap of close to $100 billion. The company has a dividend yield of 5.3% and specializes in vaccines and immunology. The company is presently working on several projects with pharma giant Sanofi, including plans to market the Advil pain reliever drug it is famous for. As part of a reformation plan, the company is also looking to sell out some of its assets, including factories in Europe and India in order to invest the money into research and development.

In the United Kingdom, the firm has teamed up with Novavax, Inc. (NASDAQ: NVAX) for vaccine production, helping reduce the dependence of the country on the AstraZeneca PLC (NASDAQ: AZN) vaccine developed by Oxford. In 2020, the firm posted profits crossing $23 million. This was less than the more than $100 million figure reported in 2019 and was attributed to the results of the pandemic. The firm is also looking to produce 200 million doses of a COVID-19 vaccine in a partnership with Sanofi and has said that it will distribute the vaccine at no profit.